Form D — Pelthos Therapeutics Inc.
0001753926-25-001126 · filed 2025-07-10
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $50,100,000
- Total sold
- $50,100,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Pelthos Therapeutics Inc.
- CIK
- 1919246
- Entity
- Corporation
- Jurisdiction
- NEVADA
- Year incorporated
- 2021
- Address
- 4020 STIRRUP CREEK DRIVE
DURHAM, NC 27703 - Phone
- 919-908-2400
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Scott Plesha · Executive OfficerDurham, NC Find on LinkedIn ↗
-
Francis Knuettel II · Executive OfficerDurham, NC Find on LinkedIn ↗
-
Sai Rangarao · Executive OfficerDurham, NC Find on LinkedIn ↗
-
Matthew Pauls · DirectorDurham, NC Find on LinkedIn ↗
-
Peter Greenleaf · DirectorDurham, NC Find on LinkedIn ↗
-
Todd Davis · DirectorDurham, NC Find on LinkedIn ↗
-
Richard Baxter · DirectorDurham, NC Find on LinkedIn ↗
-
Ezra Friedberg · DirectorDurham, NC Find on LinkedIn ↗
-
Richard Malamut · DirectorDurham, NC Find on LinkedIn ↗
View original on SEC EDGAR.